Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
The advent of immunotherapy, especially checkpoint inhibitor-based immunotherapy, has provided novel and powerful weapons against cancer. Because only a subset of cancer patients exhibit durable responses, fur...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Xiaolei Li, Changshun Shao, Yufang Shi and Weidong Han Tags: Review Source Type: research